Multiple Scedosporium apiospermum abscesses in a woman survivor of a tsunami in northeastern Japan: a case report by Yutaka Nakamura et al.
CASE REPORT Open Access
Multiple Scedosporium apiospermum abscesses
in a woman survivor of a tsunami in northeastern
Japan: a case report
Yutaka Nakamura1*, Yu Utsumi1, Naomi Suzuki1, Yoshio Nakajima1, Okinori Murata1, Nobuhito Sasaki1,
Hiroo Nitanai1, Hiromi Nagashima2, Shinya Miyamoto2, Jun Yaegashi3, Tomoki Hatakeyama3, Yoshihiro Shibano3,
Kyoko Yarita4, Katsuhiko Kamei4, Toshihide Nakadate5, Shigeatsu Endo5, Yasuo Terayama6 and Kohei Yamauchi1
Abstract
Introduction: Scedosporium apiospermum is increasingly recognized as a cause of localized and disseminated
mycotic infections in near-drowning victims.
Case presentation: We report the case of a 59-year-old Japanese woman who was a survivor of a tsunami in
northeastern Japan and who had lung and brain abscesses caused by S. apiospermum. Initially, an aspergillus
infection was suspected, so she was treated with micafungin. However, computed tomography scans of her chest
revealed lung abscesses, and magnetic resonance images demonstrated multiple abscesses in her brain. S.
apiospermum was cultured from her bronchoalveolar lavage fluid, and antimycotic therapy with voriconazole was
initiated. Since she developed an increase in the frequency of premature ventricular contractions, an adverse drug
reaction to the voriconazole was suspected. She was started on a treatment of a combination of low-dose
voriconazole and liposomal amphotericin B. After combination therapy, further computed tomography scans of the
chest and magnetic resonance images of her brain showed a demarcation of abscesses.
Conclusions: Voriconazole appeared to have a successful record in treating scedosporiosis after a near drowning
but, owing to several adverse effects, may possibly not be recommended. Thus, a combination treatment of low-
dose voriconazole and liposomal amphotericin B may be a safe and effective treatment for an S. apiospermum
infection. Even though a diagnosis of scedosporiosis may be difficult, a fast and correct etiological diagnosis could
improve the patient’s chance of recovery in any case.
Introduction
Tsunami lung occurs when a person who is over-
whelmed by tsunami waves inhales saltwater contami-
nated by mud and microorganisms. Some
microorganisms regarded as harmless saprophytes are,
with increasing frequency, being reported to cause ser-
ious or lethal infections, even in immunocompetent
individuals. Scedosporium apiospermum is increasingly
recognized as a cause of localized and disseminated
mycotic infections in near-drowning victims. This ubi-
quitous fungus is present in soil, manure, sewage, and
polluted waters. Here, we describe the case of a patient
with both lung and brain abscesses caused by S. apios-
permum and the therapeutic approach used for patients
with tsunami lung associated with near drowning.
Case presentation
A previously healthy 59-year-old Japanese woman had
been swept away by the tsunami that struck the Sanriku
coast in northeastern Japan. She aspirated saltwater con-
taminated with soil and heavy oil, which had run out
from the capsized ships. She swam back ashore and
reached a shelter at a gymnasium by herself. She was
transferred to a neighboring hospital, where she devel-
oped respiratory failure within a few hours of admission,
was intubated, and was placed on a respirator. Manage-
ment with positive end-expiratory pressure, fluid
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restriction, and broad-spectrum antibiotics did not lead
to any improvement in her pneumonia. She was referred
to our hospital five days after she had almost drowned.
Upon admission (on day six), she had a fever of 39°C, a
blood pressure of 142/92 mm Hg, and a tachycardia of
112 beats per minute. There was no evidence of trauma
or fractures anywhere on her body. Auscultation of the
chest revealed some crackles in both lungs. Her heart
sounds were normal, and the results of an abdominal
examination were normal. Her hemoglobin level was
10.0 g/dL, her platelet count was 27.4 × 1010/L, and her
white cell count 12.9 × 109/L, and she had a neutrophi-
lia of 11.7 × 109/L.
Her serum albumin was reduced to 23 g/L, and her
alkaline phosphatase was increased to 357U/L (normal
range of 99 to 340U/L). Her C-reactive protein (CRP)
was raised to 185 mg/L. Serum urea, creatinine, electro-
lytes, glucose, and coagulation were within normal refer-
ence ranges. A urine analysis showed normal findings. A
12-lead electrocardiogram showed sinus tachycardia.
Computed tomography (CT) scanning of her head was
normal and that of her chest revealed infiltration and
nodular lesions in both sides of her lungs (Figure 1).
Blood cultures were taken from our patient after admis-
sion and showed no growth. A bronchoalveolar lavage
(BAL) was performed by inserting a flexible fiberoptic
bronchoscope. The BAL fluid contained oil, sand, and
small pieces of wood. Tsunami lung was suspected, and,
in addition to an antifungal treatment, broad-spectrum
antibiotics were used, starting with 500 mg of
carbapenem intravenously three times a day (t.i.d.), 500
mg of pazufloxacin intravenously twice a day (b.i.d.),
150 mg of micafungin intravenously once a day (s.i.d.),
and steroid pulse therapy. Nevertheless, a follow-up CT
scan of the lung on day 28 showed multiple nodular
lesions of the bilateral lung and a cavity in the upper
left lobe (Figure 2), and the level of (1®3)-b-D-glucan
(from 11.7 to 110 pg/mL) had increased. Therefore, tri-
methoprim-sulfamethoxazole (trimethoprim 4.8 mg/kg t.
i.d.) and 500 mg of vancomycin intravenously four times
a day were added to the treatment. At this time, a new
BAL was examined, and although BAL fluid cultures for
common and anaerobic bacteria were also negative, fila-
mentous fungi, which seemed to be the cause in this
case, were seen. On the basis of these results, the anti-
mycotic therapy was switched to voriconazole (initially 6
mg/kg b.i.d. followed by 4 mg/kg b.i.d.). On day 36, our
patient developed a palpitation, and the frequency of
premature ventricular contractions (PVCs) increased,
although electrolyte imbalance and high concentrations
of voriconazole in the plasma were not examined. An
adverse drug reaction of voriconazole was suspected,
and the drug was withdrawn. Our patient was started
on liposomal amphotericin B (2.5 mg/kg s.i.d.) along
with trimethoprim-sulfamethoxazole, vancomycin, and
500 mg of levofloxacin intravenously s.i.d. After the
start of liposomal amphotericin B therapy, our patient’s
condition ameliorated and she was weaned successfully
from mechanical ventilation. Magnetic resonance ima-
ging of her head on day 63 revealed multiple brain
Figure 1 The chest computed tomography scan from
admission shows that nodular shadows and filtrates are
scattered in both lungs.
Figure 2 The chest computed tomography scan from day 28
shows a cavity in the left upper lobe, which has a thick wall
and is surrounded by consolidation.
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abscesses (Figure 3a,b), but the results of her physical
and neurological examinations were unremarkable,
except for the presence of a mild fever. A lumbar punc-
ture was performed but showed no white cells and no
identifiable organisms on a Gram stain or upon a cul-
ture of the cerebrospinal fluid. On day 69, the diagnosis
of S. apiospermum infection was confirmed by polymer-
ase chain reaction and DNA sequencing of cultured fila-
mentous fungi obtained from the previous BAL
specimen. Since the isolate was considered susceptible
to voriconazole (minimum inhibitory concentration
[MIC] of 0.09 μg/mL), our patient was started on low-
dose intravenous voriconazole (initially 6 mg/kg b.i.d.
followed by 2 mg/kg b.i.d.) with liposomal amphotericin
B (MIC of 1 μg/mL), which showed a relatively low
MIC against S. apiospermum. After 15 days of treatment
with a combination of voriconazole and liposomal
amphotericin B, further magnetic resonance imaging of
the head showed a demarcation of abscesses in the
brain on day 88 (Figure 3c,d). After the start of a combi-
nation therapy, the low-grade fever recurred, and the
levels of both CRP and (1®3)-b-D-glucan declined. On
day 93, a chest CT showed the size of the cavity, the
consolidation at the left upper lobe had reduced in size,
and many of the nodular shadows in the lung fields had
disappeared (Figure 4). Oral administration of voricona-
zole was substituted with intravenous voriconazole and
included the addition of oral levofloxacin 500 mg and
clarithromycin 400 mg. The voriconazole serum levels,
checked regularly, were found to be within therapeutic
limits. No recurrence was noted, and our patient was
transferred to a hospital in her hometown 96 days after
treatment had been initiated.
Discussion
S. apiospermum generally shows a high propensity to
cause central nervous system (CNS) infections. The
mode of S. apiospermum invasion and its subsequent
expansion to the CNS remains ambiguous. Probable
pathophysiological mechanisms of S. apiospermum
infection after a near drowning include a local spread
from sites near the brain, such as the paranasal sinuses
[1] or cribiform plate [2], and a hematogenous spread
from the lungs.
Voriconazole has shown efficacy in CNS-related sce-
dosporiosis refractory to treatment with other antifungal
agents, and several case reports and open-label clinical
studies have provided in vivo evidence of the efficacy
and tolerability of voriconazole as a method of therapy
in patients with Scedosporium infections [3-5]. Another
study describes voriconazole concentrations that are
higher in cerebrospinal fluid than in plasma in a female
patient [6]. Though generally well tolerated, voricona-
zole therapy may be associated with adverse events like
transient visual disturbances, hepatotoxicity, skin rashes
Figure 3 The axial fluid-attenuated inversion-recovery (FLAIR)
image shows multiple hyperintensity lesions in the left
occipital white matter and in the left internal capsule (a). The
post-contrast T1-weighted image shows multiple rounded lesions
with peripheral capsular enhancement in the corresponding area
(b). Almost four weeks later, multiple hyperintensity lesions in the
left occipital white matter and the left internal capsule (c) as well as
multiple enhanced lesions (d) are diminished in size and intensity.
Figure 4 The chest computed tomography scan from day 93
shows the cavity at the left upper lobe, which has become
reduced in size.
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[7,8], and life-threatening ventricular arrhythmia [9]. In
our patient, voriconazole appeared to be effective but
was accompanied by PVCs and so was discontinued.
However, in vitro susceptibility studies have shown that
S. apiospermum isolates are susceptible to voriconazole
and appear to have variable susceptibility to amphoteri-
cin B [5,10-13]. In our patient, susceptibility testing
according to the methods of the Clinical and Laboratory
Standards Institute was performed; the testing showed
that the MIC for amphotericin B was relatively low and
in agreement with the previous results that had higher
MICs for flucytosine, fluconazole, itraconazole, micona-
zole, and micafungin. Because enhanced antifungal
activity has been demonstrated in vitro for combinations
of amphotericin B plus azoles [14,15], we had decided
to add low-dose voriconazole to amphotericin B while
using electrocardiographic monitoring. After voricona-
zole therapy was reinstated in a low dose, adverse
events, such as PVCs, were not seen. The synergistic
interaction on our patient can be evaluated even though
low-dose voriconazole was administered.
Conclusions
In our patient, there was no evidence of fungal infec-
tions during the first month after her near-drowning
experience. In addition, repeated blood cultures
remained negative for fungi. Initially, aspergillosis was
suspected, so our patient was treated with micafungin,
although aspergillosis after near drowning seems to be
rarer than scedosporiosis [12]. Another victim of the
tsunami, who was also referred to our hospital, was a
Japanese woman with Scedosporium prolificans. Before
the fungus was diagnosed, she received treatments of
antibiotics, steroids, and extracorporeal membrane oxy-
genation. She continued to deteriorate because of infec-
tion and succumbed to septic shock. In this fatal case,
the lack of defined abscesses and specific symptoms of
fungi infection prevented antifungal treatment from
being administered. Because the detection of Scedospor-
ium was confined to the BAL from the lung abscess, it
was obviously too late for a successful antifungal ther-
apy. Katragkou and colleagues [12] reported that the
median ‘time to diagnosis of Scedosporium infection’
was 28 days. This could be attributed to the low sensi-
tivity of routine culture methods. In our patient, since
conidia had not formed, filamentous fungi were cultured
repeatedly and, on day 64, were submitted to polymer-
ase chain reaction and DNA sequencing.
The tsunami wiped out much of the medical infra-
structure, and many medications were not available.
Therefore, we propose that voriconazole be used empiri-
cally and very early in patients who have nearly
drowned. When voriconazole should not be used
because of adverse effects, the use of combined
therapies can be a promising clinical approach for com-
bating infections caused by multidrug-resistant fungi. A
fast and correct etiological diagnosis could improve the
patient’s outcome in any case.
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